Latest News in the pharma Industry

Top Stories

California Companies on Front Line against Heart Disease

California Companies on Front Line against Heart Disease

24 May 2011

The California companies are developing 188 of 887 drugs for more than 20 types of cancer and 55 of 299 medicines for heart disease and stroke.

Read more 
EMA Recommends Suspension of Oral Buflomedil-Containing Medicines

EMA Recommends Suspension of Oral Buflomedil-Containing Medicines

23 May 2011

The decision was taken because serious and sometimes fatal neurological and cardiac side effects, mainly related to accidental or intentional overdose, continued to occur.

Read more 
Takeda to Acquire Nycomed for $13.7B

Takeda to Acquire Nycomed for $13.7B

20 May 2011

Nycomed's significant business infrastructure in Europe and high-growth emerging markets are expected to enhance Takeda's regulatory development expertise and commercialization capability.

Read more 
Bill Gates Calls on Leaders for Vaccines Investment

Bill Gates Calls on Leaders for Vaccines Investment

19 May 2011

Bill Gates and his foundation calls on leaders to increase investment in vaccines and immunisation to make vaccines affordable for poor countries.

Read more 
Dalton and Zafgen Enter Manufacturing Pact

Dalton and Zafgen Enter Manufacturing Pact

19 May 2011

Dalton Pharma Services announced that it has entered into a manufacturing services agreement with Zafgen Inc.

Read more 
Tekmira Expands LNP Collaboration with BMS

Tekmira Expands LNP Collaboration with BMS

19 May 2011

BMS will have a first right to negotiate a licensing agreement on certain RNAi products developed by Tekmira that result from gene targets validated by BMS.

Read more 
Goodwin Biotechnology and Rafagen Ink Deal for Biomanufacturing

Goodwin Biotechnology and Rafagen Ink Deal for Biomanufacturing

19 May 2011

Goodwin Biotechnology and RAFAGEN jointly announced their collaborative agreement for cell line engineering and biological contract manufacturing.

Read more 
IMS: Global Spending for Medicines to Reach $1.1T by 2015

IMS: Global Spending for Medicines to Reach $1.1T by 2015

19 May 2011

Over the next five years, the emerging markets are expected to nearly double their spending on medicines, to $285-315 billion, compared with $151 billion in 2010.

Read more 
Teva To Acquire 57% of Taiyo Shares

Teva To Acquire 57% of Taiyo Shares

17 May 2011

Israel's Teva Pharmaceutical Industries is about to acquire Taiyo Pharmaceutical Industry, the third largest generic drug producer in Japan.

Read more 
Quintiles and PGT in Genomic Testing Pact

Quintiles and PGT in Genomic Testing Pact

17 May 2011

The two companies will apply large-scale genomic analyses to test clinical hypotheses and correlate biomarkers of disease prognosis and drug responsiveness.

Read more 
IMI Announces 23 Unique Projects to Boost Drug Innovation

IMI Announces 23 Unique Projects to Boost Drug Innovation

17 May 2011

The IMI launches its second wave of research projects including cancer, immune-mediated diseases, infectious disorders and electronic health.

Read more 
EU Opens Antitrust Investigation Assessing Deal between Cephalon and Teva

EU Opens Antitrust Investigation Assessing Deal between Cephalon and Teva

17 May 2011

The European Commission has launched a formal antitrust investigation to assess an agreement between Cephalon and Teva.

Read more